8 results
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
Canagliflozin - Dapagliflozin ... - Empagliflozin ... SGLT2 #Inhibitors #pharmacology
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
(Invokana) - Dapagliflozin ... (Farxiga) - Empagliflozin ... SGLT2i #Inhibitors #pharmacology
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Synjardy (metformin + empagliflozin ... Xigduo (metformin + dapagliflozin ... (linagliptin + empagliflozin ... ) • Qtern (dapagliflozin ... Tablets #Oral #DM2 #Pharmacology
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Canagliflozin • Dapagliflozin ... , empagliflozin ... #Medications #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... gliflozin): • Empagliflozin ... the three • Dapagliflozin ... loss (~2-3kg) • Empagliflozin ... SGLT2 #Inhibitors #Pharmacology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
• SGLT2i (Dapagliflozin ... #Medications #pharmacology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
inhibitors that modulate ... canagliflozin (Invokana®), dapagliflozin ... (Farxiga®) and empagliflozin ... canagliflozin, #dapagliflozin ... , #empagliflozin
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
compared to SGLT2 empagliflozin ... semaglutide #Diabetes #Pharmacology